SL Green SLG Stock Is It Worth Allocating Capital SL Green Faces NYC Office Occupancy Headwinds Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus INSG Inseego posts 604 percent Q4 2025 EPS beat shares rise 135 percent after its latest quarterly earnings release